Cancer Research and Treatment

Original Article

Clinical Analysis for Brain Tumor-Related Epilepsy during Chemotherapy for Systemic Cancer with Single Brain Metastasis: Young Zoon Kim, Eun Hee Lee, Kyoung Soo Lee; Cancer Res Treat. 2011;43(3):160-169. Published online September 30, 2011; DOI: https://doi.org/10.4143/crt.2011.43.3.160

PURPOSE
The purpose of this prospective observational study was to determine the incidence, patterns, and predisposing factors for brain tumor-related epilepsy (BTRE) during chemotherapy for systemic cancer with single brain metastasis (BM).
MATERIALS AND METHODS
Between February 2006 and June 2010, 103 patients who underwent chemotherapy for systemic cancer with single BM were enrolled. We compared the clinical factors of patients and BM between patients with and without BTRE. We determined the number of patients with BTRE attacks, and seizure-free survival according to the following comparative groups: presence vs. absence of a history of BTRE; high-risk vs. low-risk groups; and presence vs. absence of disease-progression of BM.
RESULTS
Ninety-three of 103 patients (90.3%) remained seizure-free during chemotherapy. The seizure-free rates were 88.9% and 91.0% among patients with or without a history of BTRE, respectively (p=0.694), 87.8% and 92.6% among high- and low-risk patients (p=0.427), respectively, and 62.5% and 98.7% among patients with or without disease-progression of BM (p=0.001), retrospectively. Based on multivariate analysis, the significance of abnormal findings on electroencephalogram (EEG) (p=0.017), and the absence of disease-progression of BM (p=0.001) had an association with seizure-free survival.
CONCLUSION
The significance of abnormal findings on EEG, and disease-progression of BM play important roles in the development of BTRE during chemotherapy for systemic cancer with BM.

Citations

Citations to this article as recorded by

Analysis of prognostic factors and the role of epilepsy in neurosurgical patients with brain metastases
Matteo Maria Ottaviani, Maria Rossella Fasinella, Alessandro Di Rienzo, Maurizio Gladi, Lucia Giovanna Maria di Somma, Maurizio Iacoangeli, Mauro Dobran
Surgical Neurology International.2024; 15: 79. CrossRef
Seizure outcomes in patients with brain metastases and epilepsy: a systematic review on the efficacy of antitumor treatment and antiseizure medication
Josien C C Scheepens, Pim B van der Meer, Linda Dirven, Maaike J Vos, Martin J B Taphoorn, Johan A F Koekkoek
Neuro-Oncology Practice.2024;[Epub] CrossRef
Tumor-associated epilepsy in patients with brain metastases: necrosis-to-tumor ratio forecasts postoperative seizure freedom
Majd Bahna, Muriel Heimann, Christian Bode, Valeri Borger, Lars Eichhorn, Erdem Güresir, Motaz Hamed, Ulrich Herrlinger, Yon-Dschun Ko, Felix Lehmann, Anna-Laura Potthoff, Alexander Radbruch, Christina Schaub, Rainer Surges, Johannes Weller, Hartmut Vatte
Neurosurgical Review.2022; 45(1): 545. CrossRef
Brain tumor–related epilepsy and risk factors for metastatic brain tumors: analysis of 601 consecutive cases providing real-world data
Kenichiro Asano, Seiko Hasegawa, Masashi Matsuzaka, Hiroki Ohkuma
Journal of Neurosurgery.2022; 136(1): 76. CrossRef

10,449 View
52 Download
4 Crossref

First
Prev
Page of 1
Next
Last

Search